Zobrazeno 1 - 10
of 67
pro vyhledávání: '"and G.P. Talwar"'
Autor:
Jagdish C. Gupta, G.P. Talwar
Publikováno v:
International Journal of Vaccine Research. 3:1-5
Autor:
G.P. Talwar
Human chorionic gonadotropin (hCG) is not normally made by any organ of women (or men) and emerges only after fertilization of the egg and its development as an embryo. The presence of hCG in blood is a standard test for diagnosis of pregnancy implyi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01d988bf624b40615a64a8f29c758a96
https://doi.org/10.1016/b978-0-12-820050-6.00019-9
https://doi.org/10.1016/b978-0-12-820050-6.00019-9
Autor:
Thommas Kwenko Abban, Robert C. Baxter, Giulia Brigante, Stephen A. Butler, Livio Casarini, Laurence A. Cole, Jemma Evans, Mazen R. Founay, Thierry Fournier, Nicholas Gibbons, Jagdish C. Gupta, Trine Grønhaug Halvorsen, Ilpo T. Huhtaniemi, Ray K. Iles, Anna Jankowska, Sarah Johnson, R.S. Kabeer, Hannu K. Koistinen, Clara Lazzaretti, Jameel Luttoo, Deborah J. Marsh, Ricardo J. Pais, Elia Paradiso, Matti Poutanenn, Shilpi Puruswani, Léon Reubesat, Susana B. Rulli, Daniele Santi, Fady I. Sharara, Manuela Simoni, Snega M. Sinnappan, Ulf-Håkan Stenman, Vernon C. Stevens, Anna Szczerba, G.P. Talwar, Hemant K. Vyas, Raminta Zmuidinaite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02fa9b0e8f017641da0ef75605172736
https://doi.org/10.1016/b978-0-12-820050-6.01002-x
https://doi.org/10.1016/b978-0-12-820050-6.01002-x
Human chorionic gonadotropin (hCG) is normally made by the early embryo soon after fertilization of the egg. It plays a vital role in the implantation of embryos and in sustenance of pregnancy. Neither nonpregnant females nor healthy males make this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ce0c0666cb4aeddb8a70391447f05f4
https://doi.org/10.1016/b978-0-12-820050-6.00026-6
https://doi.org/10.1016/b978-0-12-820050-6.00026-6
Publikováno v:
World Journal of Clinical Oncology
AIM To investigate the therapeutic potential of two recombinant proteins, Survivin and luteinizing hormone-releasing hormone (LHRH) fusion protein [LHRH(6leu)-LTB] for immunotherapy of breast cancer. METHODS Murine 4T-1 breast cancer model was used t
Autor:
G.P. Talwar, Jagdish C Gupta
Publikováno v:
Investigations in Gynecology Research & Womens Health (IGRWH). 2
Autor:
G.P. Talwar, Sapan Gupta, M. Diwan, S. N. Wadhwa, Hemant K. Vyas, Shilpi Purswani, Jagdish C. Gupta, J. Frick, R. M. Gupta, S. K. Sharma
Publikováno v:
Journal of Cancer Therapy. :370-377
This review describes briefly the beneficial use of two vaccines developed by us for treatment of cancers. The vaccine against Luteinizing Hormone Releasing Hormone (LHRH) is effective in carcinoma of prostate as well as in breast cancers dependent o
Publikováno v:
Journal of Reproductive Health and Medicine. 2:37-42
A brief overview is given of a vaccine that is competent to prevent pregnancy without any disturbance of normal ovulation, normal making of sex steroids, and menstrual regularity. It requires periodic intake and offers full privacy of use to the wome
Autor:
Jagdish C. Gupta, Kripa N Nand, S. N. Wadhwa, Rajesh K. Naz, G.P. Talwar, Sapan Gupta, J. Frick
Publikováno v:
Archives of Microbiology & Immunology. :1-11
Conjugation of hCGβ subunit with tetanus toxoid generates simultaneously independent set of antibodies against both hCG and tetanus. The former are competent to neutralise the bioactivity of hCG, and the latter impart immunoprophylactic benefit agai
Publikováno v:
Preparative biochemistrybiotechnology. 48(3)
Survivin has received attention as a potential target for cancer immunotherapy because of its crucial role in oncogenesis. We undertook this study to evaluate the immunotherapeutic potential of combination of recombinant survivin along with adjuvant